Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Intuitive Surgical    ISRG

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Intuitive Surgical, Inc. : Hagens Berman Notifies Investors of June 25, 2013, Lead Plaintiff Deadline in Intuitive Surgical, Inc. Securities Class Action

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/29/2013 | 03:30pm CEST

Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, today notified investors of a pending June 25, 2013, deadline to file for lead plaintiff in a securities class-action lawsuit brought again Intuitive Surgical, Inc. (NASDAQ: ISRG) ("ISRG" or "the company"). The firm encourages investors with more than $500,000 in losses to contact Hagens Berman Partner Reed Kathrein to discuss moving for lead plaintiff by emailing ISRG@hbsslaw.com or calling (510) 725-3000.

Investors who purchased ISRG common stock between Oct. 19, 2011, and April 18, 2013, (the "class period") and have more than $500,000 in losses can also reach an attorney by visiting http://www.hb-securities.com/investigations/ISRG.

The lawsuit, filed in U.S. District Court for the Northern District of California on April 26, 2013, alleges that ISRG issued a series of false or misleading statements to investors during the class period. The suit alleges that ISRG failed to fully disclose to investors the financial impact of safety problems with its da Vinci Surgical System, including a number of deaths allegedly caused by the system.

A number of lawsuits have been filed against the company seeking damages for injuries caused by da Vinci. Following media coverage of those suits, ISRG's stock price suffered a significant decline. The filed investor lawsuit claims that ISRG deceived investors regarding the risk of Food and Drug Administration action against the company.

"We are concerned that ISRG failed to come clean with investors, especially in light of a significant number of deaths reported to the FDA," said Mr. Kathrein. "We are concerned that the company may be exposed to significant financial losses, either due to potential FDA restrictions on da Vinci or damages in pending personal injury lawsuits."

Investors who wish to serve as lead plaintiff in the case must move the court no later than June 25, 2013. Any member of the putative class may move the Court to serve as lead plaintiff through counsel of their choice, or may choose to do nothing and remain an absent class member.

Hagens Berman reminds whistleblowers with inside information that rewards may be available to individuals who report information leading to a successful enforcement action by the Securities and Exchange Commission. Under the new SEC whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC.

About Hagens Berman

Hagens Berman Sobol Shapiro LLP is an investor-rights class-action law firm with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the law firm and its successes can be found at www.hbsslaw.com. The Firm's securities law blog is at http://www.meaningfuldisclosure.com.

Firmani + Associates
Mark Firmani, 206-443 9357
Mark@firmani.com


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on INTUITIVE SURGICAL
07/21 INTUITIVE SURGICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION..
07/21 INTUITIVE SURGICAL, INC. (NASDAQ : ISRG) reported earnings of $5.95 per share be..
07/20 INTUITIVE SURGICAL : tops Street 2Q forecasts
07/20 INTUITIVE SURGICAL, INC. (NASDAQ : ISRG) Files An 8-K Results of Operations and ..
07/20 INTUITIVE SURGICAL INC : Results of Operations and Financial Condition (form 8-K..
07/20 Intuitive Surgical Announces Second Quarter Earnings
07/20 INTUITIVE SURGICAL : Investor Network: Intuitive Surgical, Inc. to Host Earnings..
07/19 INTUITIVE SURGICAL : Reports New Employee Option Grants for July 2017
07/18 INTUITIVE SURGICAL : Reports New Employee Option Grants for July 2017
07/06 INTUITIVE SURGICAL : "Guided Setup for Teleoperated Medical Device" in Patent Ap..
More news
News from SeekingAlpha
07/21 Sell-siders bullish on Intuitive Surgical after Q2 beat; shares down 4%
07/20 Intuitive Surgical's (ISRG) CEO Gary Guthart on Q2 2017 Results - Earnings Ca..
07/20 Intuitive Surgical Q2 top line up 13%; earnings up 20%; shares up 1% after ho..
07/20 Intuitive Surgical beats by $0.16, beats on revenue
07/19 Notable earnings after Thursday?s close
Financials ($)
Sales 2017 3 030 M
EBIT 2017 1 236 M
Net income 2017 819 M
Finance 2017 2 563 M
Yield 2017 -
P/E ratio 2017 44,38
P/E ratio 2018 39,38
EV / Sales 2017 10,4x
EV / Sales 2018 9,07x
Capitalization 34 169 M
Chart INTUITIVE SURGICAL
Duration : Period :
Intuitive Surgical Technical Analysis Chart | ISRG | US46120E6023 | 4-Traders
Technical analysis trends INTUITIVE SURGICAL
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 996 $
Spread / Average Target 7,4%
EPS Revisions
Managers
NameTitle
Gary S. Guthart President, Chief Executive Officer & Director
Lonnie M. Smith Chairman
Marshall L. Mohr Chief Financial Officer & Senior Vice President
Myriam J. Curet Chief Medical Officer & Senior Vice President
Alan J. Levy Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
INTUITIVE SURGICAL46.25%34 169
THERMO FISHER SCIENTIFIC INC.29.11%71 272
DANAHER6.69%57 694
BOSTON SCIENTIFIC CORPORATION27.69%37 823
ROYAL PHILIPS6.86%33 996
ILLUMINA34.92%25 273